Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kingsley

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Journal of Medicinal Chemistry|July 7, 1995
Cyclic variations of 3-quinolinecarboxamides and effects on antiherpetic activityM P Wentland, J A Carlson, P H Dorff, et al.
Journal of Medicinal Chemistry|August 18, 1995
Keto/enol epoxy steroids as HIV-1 Tat inhibitors: structure-activity relationships and pharmacophore localizationW F Michne, J D Schroeder, T R Bailey, et al.
Stem Cell Reports|June 2, 2015
Bmi-1 Regulates Extensive Erythroid Self-RenewalAh Ram Kim, Jayme L Olsen, Samantha J England, et al.
The EMBO Journal|October 17, 2024
An Orai1 gain-of-function tubular aggregate myopathy mouse model phenocopies key features of the human diseaseNan Zhao, Antonio Michelucci, Laura Pietrangelo, et al.
Experimental Hematology|February 5, 2011
Sublethal radiation injury uncovers a functional transition during erythroid maturationScott A Peslak, Jesse Wenger, Jeffrey C Bemis, et al.
Journal of Cellular Physiology|September 25, 2004
Overlapping expression of Runx1(Cbfa2) and Runx2(Cbfa1) transcription factors supports cooperative induction of skeletal developmentNathan Smith, Yufeng Dong, Jane B Lian, et al.
Science (New York, N.Y.)|February 9, 2008
A heme export protein is required for red blood cell differentiation and iron homeostasisSiobán B Keel, Raymond T Doty, Zhantao Yang, et al.
Radiation Research|June 21, 2021
Long-acting PGE2 and Lisinopril Mitigate H-ARSJ Saunders, L M Niswander, K E McGrath, et al.
Investigational New Drugs|April 3, 2014
Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancerJohanna C Bendell, Heinz-Josef Lenz, Theresa Ryan, et al.
Developmental Cell|March 21, 2020
Potently Cytotoxic Natural Killer Cells Initially Emerge from Erythro-Myeloid Progenitors during Mammalian DevelopmentCarissa Dege, Katherine H Fegan, J Philip Creamer, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Journal of Medicinal Chemistry|July 7, 1995
Cyclic variations of 3-quinolinecarboxamides and effects on antiherpetic activityM P Wentland, J A Carlson, P H Dorff, et al.
Journal of Medicinal Chemistry|August 18, 1995
Keto/enol epoxy steroids as HIV-1 Tat inhibitors: structure-activity relationships and pharmacophore localizationW F Michne, J D Schroeder, T R Bailey, et al.
Stem Cell Reports|June 2, 2015
Bmi-1 Regulates Extensive Erythroid Self-RenewalAh Ram Kim, Jayme L Olsen, Samantha J England, et al.
The EMBO Journal|October 17, 2024
An Orai1 gain-of-function tubular aggregate myopathy mouse model phenocopies key features of the human diseaseNan Zhao, Antonio Michelucci, Laura Pietrangelo, et al.
Experimental Hematology|February 5, 2011
Sublethal radiation injury uncovers a functional transition during erythroid maturationScott A Peslak, Jesse Wenger, Jeffrey C Bemis, et al.
Journal of Cellular Physiology|September 25, 2004
Overlapping expression of Runx1(Cbfa2) and Runx2(Cbfa1) transcription factors supports cooperative induction of skeletal developmentNathan Smith, Yufeng Dong, Jane B Lian, et al.
Science (New York, N.Y.)|February 9, 2008
A heme export protein is required for red blood cell differentiation and iron homeostasisSiobán B Keel, Raymond T Doty, Zhantao Yang, et al.
Radiation Research|June 21, 2021
Long-acting PGE2 and Lisinopril Mitigate H-ARSJ Saunders, L M Niswander, K E McGrath, et al.
Investigational New Drugs|April 3, 2014
Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancerJohanna C Bendell, Heinz-Josef Lenz, Theresa Ryan, et al.
Developmental Cell|March 21, 2020
Potently Cytotoxic Natural Killer Cells Initially Emerge from Erythro-Myeloid Progenitors during Mammalian DevelopmentCarissa Dege, Katherine H Fegan, J Philip Creamer, et al.
Pageof 14